Venus Concept Inc. (NASDAQ:VERO) Sees Large Decline in Short Interest

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totalling 55,500 shares, a decline of 42.6% from the December 15th total of 96,700 shares. Based on an average trading volume of 946,700 shares, the short-interest ratio is currently 0.1 days. Currently, 1.3% of the company’s shares are short sold.

Institutional Trading of Venus Concept

An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC raised its position in Venus Concept Inc. (NASDAQ:VERO) by 100.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. Institutional investors own 87.41% of the company’s stock.

Venus Concept Stock Performance

VERO stock opened at $0.35 on Wednesday. The business’s 50-day moving average price is $0.35 and its two-hundred day moving average price is $0.49. The company has a current ratio of 1.86, a quick ratio of 1.18 and a debt-to-equity ratio of 2.83. The firm has a market cap of $2.56 million, a PE ratio of -0.04 and a beta of 0.47. Venus Concept has a 1-year low of $0.28 and a 1-year high of $2.22.

Venus Concept Company Profile

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.